Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Boosting Next-Gen Mental Health Care: Enveric's New US Patent For Anxiety Treatment
August 28, 2023
Tickers
ENVB
Tags
Legal
News
United States Patent and Trademark Office (USPTO)
From
Benzinga
Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More
August 28, 2023
Tickers
ATAI
CMPS
CYBN
DRUG
Tags
Kyle Quincey
MNMD
ATAI
From
Benzinga
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety
August 28, 2023
Tickers
CYBN
DMTTF
Tags
DMTTF
Markets
Guidance
From
Benzinga
Cracking The Code Of Healing: Can Trained Coders Observe Therapeutic Moments In Psilocybin Therapy?
August 25, 2023
Tags
Cannabis
Markets
Market News
From
Benzinga
Funding The Future Of Psychedelics: Cybin Launches Renewed ATM Equity Program Up To $35M
August 24, 2023
Tickers
CYBN
Tags
Benzinga
Penny Stocks
Psychedelic/Assisted Therapies
From
Benzinga
GH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026
August 24, 2023
Tickers
GHRS
Tags
Psychedelic/Assisted Therapies
GHRS
Benzinga
From
Benzinga
Canada Vs. US: Surveys Reveal How People Use Psychedelics, Relationships With Healthcare Providers
August 23, 2023
Tags
Benzinga
Psychedelic/Assisted Therapies
NIDA
From
Benzinga
Federico Fellini's LSD Journey: How It Inspired Some Of The Greatest Films Of All Time
August 23, 2023
Tags
Markets
Federico Fellini
News
From
Benzinga
Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
August 21, 2023
Tickers
ATAI
CMPS
CYBN
DRUG
Tags
Cannabis
SILO
SCTL
From
Benzinga
Psychedelics IP Protection: Cybin Nabs US Patent For Deuterated Analogs, Psilera Advances Next-Gen Library
August 16, 2023
Tickers
CYBN
Tags
Cannabis
Market News
Benzinga
From
Benzinga
$21.8M Revenue For NASDAQ-Listed Psychedelics Ancillary Company Societal CDMO's Q2 2023
August 16, 2023
Tickers
SCTL
Tags
SCTL
Market News
Cannabis
From
Benzinga
Filament Health Shares Q1 2023 Financials, Material Uncertainties Upon Securing Additional Financing
August 15, 2023
Tickers
FLHLF
JAQC
Tags
Market News
Cannabis
Psychedelic/Assisted Therapies
From
Benzinga
Mydecine Releases Q2 2023: Developer Of Smoke Cessation Psilocybin Prodrugs & MDMA Analogs
August 15, 2023
Tickers
MYCOF
Tags
Management
MYCOF
News
From
Benzinga
Cybin's Q1 2023 Financials, Deuterated Psychedelics Moving 'Steadily' Through The Clinic
August 14, 2023
Tickers
CYBN
Tags
Guidance
Markets
Earnings
From
Benzinga
Enveric's Q2 2023 Financials Show Immediate Need For Budget-Slimming Toward A Clinical-Staged 2024
August 14, 2023
Tickers
ENVB
Tags
Market News
Cannabis
Financing
From
Benzinga
MindMed Inks $50M Credit Facility Deal With K2 HealthVentures For An Additional Operational Year
August 14, 2023
Tickers
MNMD
Tags
Management
MNMD
K2 HealthVentures
From
Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
August 14, 2023
Tickers
AGNPF
ATAI
AWKNF
CMPS
Tags
Benzinga
Penny Stocks
Amanda Feilding
From
Benzinga
Multifaceted Artist Kid Cudi Opens Up About Psychedelics, Rehab, Fashion Brand Launch & Being An OG
August 13, 2023
Tags
News
Management
Markets
From
Benzinga
Atai's Q2 2023 Plus Clinical Data On Ibogaine-Opioid Study, Pipeline's Psilocybin, DMT, Ketamine & MDMA
August 10, 2023
Tickers
ATAI
CMPS
Tags
Earnings
News
opioid use disorder
From
Benzinga
SXSW 2024's Voting Period For 100+ Marijuana & Psychedelics Panels Is On & Upcoming Events Around The Globe
August 09, 2023
Tags
Cannabis
Markets
Market News
From
Benzinga
Atai's Clinical Results Of R-Ketamine For Depression: Road To Subcutaneous At-Home Administration
August 09, 2023
Tickers
ATAI
JNJ
Tags
Psychedelics
Contracts
Drug Delivery Technologies
From
Benzinga
Breaking Ground In Prevention & Relief Of Anxiety & PTSD: Silo Pharma' Nasal Formulation For Ketamine-Based Treatment
August 08, 2023
Tickers
SILO
Tags
Market News
SILO
Cannabis
From
Benzinga
Bright Mind Shares Surge 91% After Reporting Positive EEG Clinical Results Of Next-Gen Compound
August 08, 2023
Tickers
DRUG
Tags
Cannabis
Market News
Benzinga
From
Benzinga
First Ever Professional Practice Guidelines For Providing Psychedelic-Assisted Therapy Published
August 08, 2023
Tags
Management
News
American Psychedelic Practitioners Association
From
Benzinga
Cybin Closes Short-Lasting Overnight Public Offering With Top Issuance For $8.25M
August 04, 2023
Tickers
CYBN
Tags
Markets
Guidance
Public Offering
From
Benzinga
Another Spending Bill Makes Its Way Through Senate, Could Amplify Marijuana & Psychedelics Research
August 03, 2023
Tags
Markets
News
Psychedelics Reform
From
Benzinga
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
August 03, 2023
Tickers
ATAI
AWKNF
CMPS
CYBN
Tags
LSDI
ATAI
PMBHF
From
Benzinga
Eliza Dushku & Peter Palandjian Donate $7.5M To Brigham And Women's Hospital For Substance Use Disorder Research
August 02, 2023
Tags
Cannabis
Financing
Market News
From
Benzinga
Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player
August 01, 2023
Tickers
MGCLF
OPTHF
TRUFF
Tags
Markets
TRUFF
News
From
Benzinga
Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details
August 01, 2023
Tickers
REUN
Tags
Legal
Management
News
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.